Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
274
-
Total 13F shares, excl. options
-
108M
-
Shares change
-
+4.86M
-
Total reported value, excl. options
-
$3.68B
-
Value change
-
+$241M
-
Put/Call ratio
-
2.82
-
Number of buys
-
121
-
Number of sells
-
-168
-
Price
-
$34.19
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2014
354 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2014.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 108M shares
.
Largest 10 shareholders include ROYCE & ASSOCIATES LLC (9.44M shares), BAILLIE GIFFORD & CO (8.67M shares), Capital Research Global Investors (8.43M shares), VANGUARD GROUP INC (4.87M shares), Capital World Investors (3.2M shares), FMR LLC (2.86M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (2.57M shares), TIGER GLOBAL MANAGEMENT LLC (2.35M shares), SCOPIA CAPITAL MANAGEMENT LLC (2.33M shares), and FIRST TRUST ADVISORS LP (2.33M shares).
This table shows the top 274 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.